PharmaSecure, a leading provider of anti-counterfeiting and patient adherence solutions was
awarded by Dr. Reddy’s at its 2016 MPOWER annual event for its ‘Patient Adherence
Dr.Reddy’s hosted its annual brand event MPOWER to recognize the contributions of
outstanding individuals and partners over the Financial Year 2016. PharmaSecure was
recognized as a ‘Valuable Partner’ for its effort in the field of Patient Adherence.
PharmaSecure has been working with Dr.Reddy’s to provide patient adherence services for
select brands over the past few years.
Adherence is the degree to which a patient follows her treatment regimen. India faces a major
challenge of patient non-compliance as a large number of patients do not take their medicines
or treatment as prescribed. PharmaSecure employs its psConnect platform to address the
problem of non-adherence in order to improve health outcome in the country.
Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated pharmaceutical company, committed
to providing affordable and innovative medicines for healthier lives. Through its three
businesses – Pharmaceutical Services & Active Ingredients, Global Generics and Proprietary
Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated formulations. Our major
therapeutic areas of focus are gastro-intestinal, cardiovascular, diabetology, oncology, pain
management and anti-infectives. Dr. Reddy’s operates in markets across the globe. Our major
markets include – USA, Russia & CIS and India.